Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_assertion description "[Associations of epidermal growth factor (EGF) 61A>G, EGF receptor (EGFR) CA(14-22), cyclin D1 (CCND1) 932G>A, fragment-C gamma receptor (FCGR) 2A 535A>G and FCGR3A 818A>C polymorphisms with progression-free survival (PFS) and cetuximab-related skin toxicity were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_assertion evidence source_evidence_literature NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_assertion SIO_000772 20418097 NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_assertion wasDerivedFrom befree-20140225 NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_assertion wasGeneratedBy ECO_0000203 NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.